Use of the S-100 Protein as a Tumour Marker in Malignant Melanoma

Czech version

Authors: E. Minariková ¹; R. Pullmann ²; N. Karafová ²; J. Péč ¹; Z. Frličková ¹; Ľ. Lauko ³
Authors‘ workplace: Dermatovenerologická klinika JLF UK a Martinskej fakultnej nemocnice, prednosta prof. MUDr. J. Péč, CSc. 2Ústav klinickej biochémie JLF UK a Martinskej fakultnej nemocnice, prednosta prof. MUDr. RNDr. R. Pullmann, CSc. 3Ústav patologickej anatómie JLF UK ¹
Published in: Čes-slov Derm, , 2003, No. 4, p. 156-158
Category:

Overview

The authors present results of determinations of S-100 protein in the serum by the immunoradiologicalmethodin the Sangtec S-100 IRMA test in 109 patients in four stages of malignant melanomain the years 2000-2002. In the series of patients there have been found the highest mean values of15.4

Key words:
S-100 protein - malignant melanoma - tumour marker

Full text is not available online.

If interested in a scan of this journal, contact NTO ČLS JEP.

Labels

Dermatology & STDs Paediatric dermatology & STDs

Palmo-plantar Erythrodysesthesia caused by Liposome-encapsulated Doxorubicin

Granular Parakeratosis

Malignant Eccrine Poroma (Eccrine Porocarcinoma)

Digitalized Dermatoscopy in Investigation of Pigmented Skin Lesions (PreliminaryClinical Experience)

Fibrous Nodules in Lyme Borreliosis

Article was published in

Czech-Slovak Dermatology

2003 Issue 4